[1] Malaguarnera, M., Vacante, M., Russo, C., Malaguarnera, G., Antic, T., Malaguarnera, L., Bella, R., Pennisi, G., Galvano, F. and Frigiola, A. (2013) Lipoprotein(a) in Cardiovascular Diseases. BioMed Research International, 2013, Article ID: 650989.
http://dx.doi.org/10.1155/2013/650989
[2] Utermann, G. (2001) Lipoprotein(a). In: Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D., Eds., The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, New York, 2753-2787.
[3] Hikita, H., Shigeta, T., Kojima, K., Oosaka, Y., Hishikari, K., Kawaguchi, N., Nakashima, E., Sugiyama, T., Akiyama, D., Kamiishi, T., Kimura, S., Takahashi, Y., Kuwahara, T., Sato, A., Takahashi, A. and Isobe, M. (2013) Lipoprotein(a) Is an Important Factor to Determine Coronary Artery Plaque Morphology in Patients with Acute Myocardial Infarction. Coronary Artery Disease, 24, 381-385.
http://dx.doi.org/10.1097/MCA.0b013e3283622329
[4] Kostner, K.M. and Kostner, G.M. (2005) Therapy of Hyper-Lp(a). In: von Eckardstein, A., Ed., Atherosclerosis: Diet and Drugs, Springer, Heidelberg, 519-536.
http://dx.doi.org/10.1007/3-540-27661-0_19
[5] Wang, Y.T., von Zychlinski, A. and McCormick, S.P. (2009) Dimyristoylphosphotidylcholine Induces Conformational Changes in apoB That Lowers Lipoprotein(a). Journal of Lipid Research, 50, 846-853.
http://dx.doi.org/10.1194/jlr.M800428-JLR200
[6] Hjeltnes, G., Hollan, I., Forre, O., Wiik, A., Lyberg, T., Mikkelsen, K. and Agewall, S. (2013) Serum Levels of Lipoprotein(a) and E-Selectin Are Reduced Rheumatoid Arthritis Patients Treated with Methotrexate or Methotrexate in Combination with TNF-α-Inhibitor. Clinical and Experimental Rheumatology, 31, 415-421.
[7] Schultz, O., Oberhauser, F., Saech, J., Rubbert-Roth, A., Hahn, M., Krone, W. and Laudes, M. (2010) Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein(a) Levels in Human Subjects with Rheumatoid Diseases. PLoS One, 5, e14328.
http://dx.doi.org/10.1371/journal.pone.0014328
[8] Berglund, L. and Ramakrishnan, R. (2004) Lipoprotein(a): An Elusive Cardiovascular Risk Factor. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 2219-2226.
http://dx.doi.org/10.1161/01.ATV.0000144010.55563.63
[9] Loscalzo, J. (1990) Lipoprotein(a). A Unique Risk Factor for Atherothrombotic Disease. Arteriosclerosis, 10, 672-679.
http://dx.doi.org/10.1161/01.ATV.10.5.672
[10] Fan, J., Shimoyamada, H., Sun, H., Marcovina, S., Honda, K. and Watanabe, T. (2001) Transgenic Rabbits Expressing Human Lipoprotein(a) Develop More Extensive Atherosclerotic Lesions in Response to a Cholesterol-Rich Diet. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 88-94.
http://dx.doi.org/10.1161/01.ATV.21.1.88
[11] Kooshki, A., Taleban, F.A., Tabibi, H. and Hedayati, M. (2011) Effects of ω-3 Fatty Acids on Serum Lipids, Lipoprotein(a) and Hematologic Factors in Hemodialysis Patients. Renal Failure, 33, 892-898.
http://dx.doi.org/10.3109/0886022X.2011.605536
[12] Fischer, S., Schatz, U. and Julius, U. (2013) Current Standards in Diagnosis and Therapy of Hyperlipoproteinemia. Atherosclerosis Supplements, 14, 15-18.
http://dx.doi.org/10.1016/j.atherosclerosissup.2012.10.035
[13] Makino, K., Abe, A., Maeda, S., Noma, A., Kawade, M. and Takenaka, O. (1989) Lipoprotein(a) in Nonhuman Primates Presence and Characteristics of Lp(a) Immunoreactive Materials Using Anti-Human Lp(a) Serum. Atherosclerosis, 78, 81-85.
http://dx.doi.org/10.1016/0021-9150(89)90161-5
[14] Vogt, A. and Parhofer, K.G. (2013) The Potential of Mipomersen, an ApoB Synthesis Inhibitor, to Reduce Necessity for LDL-Apheresis in Patients with Heterozygous Familial Hypercholesterolemia and Coronary Artery Disease. Expert Opinion on Pharmacotherapy, 14, 691-697.
http://dx.doi.org/10.1517/14656566.2013.779253
[15] Kostner, G.M., Klein, G. and Krempler, F. (1984) Can Serum Lp(a) Concentrations Be Lowered by Drugs and/or Diet? In: Carlson, L.A. and Olsson, A.G., Eds., Treatment of Hyperlipoproteinemia, Raven Press, New York, 151-156.
[16] Resources Council of the Science and Technology Agency (1982) Standard Tables of Food Composition in Japan. 4th Reviseded, The Science and Technology Agency, Tokyo.
[17] Albers, J.J., Adolphson, J.L. and Hazzard, W.R. (1977) Radioimmunoassay of Human Lp(a) Lipoprotein. Journal of Lipid Research, 18, 331-338.
[18] Masarei, J.R., Rouse, I.L., Lynch, W.J., Robertson, K., Vandongen, R. and Beilin, L.J. (1984) Effects of Lacto-Ovo Vegetarian Diet on Serum Concentrations of Cholesterol, Triglyceride, HDL-C, HDL2-C, HDL-3C, Apoprotein-B and Lp(a). The American Journal of Clinical Nutrition, 40, 468-478.
[19] Faghihnia, N., Tsimikas, S., Miller, E.R., Witztum, J.L. and Krauss, R.M. (2010) Changes in Lipoprotein(a), Oxidized Phospholipids and LDL Subclasses with a Low-Fat High-Carbohydrate Diet. Journal of Lipid Research, 51, 3324-3330.
http://dx.doi.org/10.1194/jlr.M005769